{"id":162358,"date":"2022-05-23T01:48:20","date_gmt":"2022-05-23T05:48:20","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/press-release-fda-approves-dupixent-dupilumab-as-first-treatment-for-adults-and-children-aged-12-and-older-with-eosinophilic-esophagitis\/"},"modified":"2024-08-18T11:44:33","modified_gmt":"2024-08-18T15:44:33","slug":"press-release-fda-approves-dupixent-dupilumab-as-first-treatment-for-adults-and-children-aged-12-and-older-with-eosinophilic-esophagitis","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/press-release-fda-approves-dupixent-dupilumab-as-first-treatment-for-adults-and-children-aged-12-and-older-with-eosinophilic-esophagitis.php","title":{"rendered":"Press Release: FDA approves Dupixent\u00ae (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis"},"content":{"rendered":"<p><![CDATA[FDA approves Dupixent\u00ae (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis]]><\/p>\n<p>Originally posted here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/05\/20\/2447906\/0\/en\/Press-Release-FDA-approves-Dupixent-dupilumab-as-first-treatment-for-adults-and-children-aged-12-and-older-with-eosinophilic-esophagitis.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Press Release: FDA approves Dupixent\u00ae (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis\">Press Release: FDA approves Dupixent\u00ae (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Originally posted here: Press Release: FDA approves Dupixent\u00ae (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/press-release-fda-approves-dupixent-dupilumab-as-first-treatment-for-adults-and-children-aged-12-and-older-with-eosinophilic-esophagitis.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162358","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162358"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162358"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162358\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}